Achieving a flexible, integrated, and sustainable cryogenic cold chain ecosystem Critical first and final steps in a cell therapy’s journey to clinic (2)

The needs, challenges, and priorities of cell therapy developers have greatly evolved over the past decade. How can we continue this momentum to overcome existing obstacles and advance the cell therapy journey to commercialization?

At this digital meeting, global experts joined to share experiences, lessons, and insight into why the industry needs flexible, integrated, and connected solutions. This discussion examined key factors in the efficient manufacturing of critical cell therapies, including:

  • Robust and reliant supply chains
  • Digitally connected solutions
  • Sustainable cryogenic ecosystems

Representatives from Cytiva’s cell therapy team also shared the latest products and services designed to enable a robust, automated, and effective cell therapy process.

2021 Speakers

Beth Webb

Commercial GM, Cell & Gene Therapy


Dr Stephen Ward

Chief Manufacturing Officer

Cell and Gene Therapy Catapult

David Brochu

Chief Technical Officer

Autolus Therapeutics

Alex Guite, Ph.D

Vice President, Services and Alliances

World Courier & ICS

Amittha Wickrema, Ph.D.

Professor of Medicine, Director, Advanced Cellular Therapeutics Facility, Faculty Director, Cellular & Tissue based Processing cGMP Facility Hematology/Oncology Section, Dept. of Medicine

University of Chicago

Christopher Herbert

Director of Operations, Research and Innovation

Leeds Teaching Hospitals NHS Trust

Sonia Bulsara

Application Specialist Leader


Yen Kong

Field Application Scientist


In Partnership with Cytiva:


Cytiva is a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Previously GE Healthcare Life Sciences, Cytiva’s diverse portfolio includes well-recognized brands such as ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Whatman and Xcellerex. Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the delivery of transformative medicines to patients.

Visit for more.